Chemours Company (CC)
14.11 x 5 14.35 x 2
Pre-market by (Cboe BZX)
13.83 -0.32 (-2.26%) 03/26/25 [NYSE]
14.11 x 5 14.35 x 2
Pre-market 13.83 unch (unch) 19:00 ET
for Wed, Mar 26th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 5,782,000 | 6,078,000 | 6,831,000 | 6,345,000 | 4,969,000 |
Cost of Goods | 4,631,000 | 4,772,000 | 5,215,000 | 4,964,000 | 3,902,000 |
Gross Profit | 1,151,000 | 1,306,000 | 1,616,000 | 1,381,000 | 1,067,000 |
Operating Expenses | 810,000 | 1,551,000 | 844,000 | 705,000 | 700,000 |
Operating Income | 341,000 | -245,000 | 772,000 | 676,000 | 367,000 |
Interest Expense | 264,000 | 208,000 | 163,000 | 185,000 | 210,000 |
Other Income | 50,000 | 135,000 | 132,000 | 185,000 | 22,000 |
Pre-tax Income | 127,000 | -318,000 | 741,000 | 676,000 | 179,000 |
Income Tax | 41,000 | -81,000 | 163,000 | 68,000 | -40,000 |
Net Income Continuous | 86,000 | -237,000 | 578,000 | 608,000 | 219,000 |
Minority Interests | N/A | 1,000 | N/A | N/A | N/A |
Net Income | $86,000 | $-238,000 | $578,000 | $608,000 | $219,000 |
EPS Basic Total Ops | 0.58 | -1.60 | 3.72 | 3.69 | 1.33 |
EPS Basic Continuous Ops | 0.58 | -1.59 | 3.72 | 3.69 | 1.33 |
EPS Diluted Total Ops | 0.57 | -1.60 | 3.65 | 3.60 | 1.32 |
EPS Diluted Continuous Ops | 0.57 | -1.59 | 3.65 | 3.60 | 1.32 |
EPS Diluted Before Non-Recurring Items | 1.21 | 2.82 | 4.66 | 4.00 | 1.98 |
EBITDA(a) | $710,000 | $71,000 | $1,072,000 | $1,002,000 | $696,000 |